{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T12:10:09Z","timestamp":1739103009037,"version":"3.37.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.trim.2024.102166","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T16:22:01Z","timestamp":1734798121000},"page":"102166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Interferon gamma release assay has potential in the prediction of chronic graft-versus-host disease in recipients of myeloablative allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis"],"prefix":"10.1016","volume":"88","author":[{"given":"Mark\u00e9ta","family":"\u0160\u0165astn\u00e1-Markov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavla","family":"Pecherkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0160\u00e1rka","family":"N\u011bme\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitka","family":"Kry\u0161tofov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0160\u00e1rka","family":"Van\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Vydra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate\u0159ina","family":"Roubalov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.trim.2024.102166_bb0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MOH.0b013e328353bc7d","article-title":"Immune reconstitution after hematopoietic cell transplantation","volume":"19","author":"Bosch","year":"2012","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.trim.2024.102166_bb0010","first-page":"7","article-title":"Functional reconstitution of natural killer cells in allogeneic hematopoietic stem cell transplantation","author":"Ullah","year":"2016","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.trim.2024.102166_bb0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/bmt.2009.255","article-title":"Background to hematopoietic cell transplantation, including post transplant immune recovery","volume":"44","author":"Mackall","year":"2009","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.trim.2024.102166_bb0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s40778-015-0027-z","article-title":"T cell immunotherapy for immune reconstitution and GVHD prevention after allogeneic hematopoietic stem cell transplantation","volume":"1","author":"Lucarelli","year":"2015","journal-title":"Curr. Stem Cell Rep."},{"issue":"8","key":"10.1016\/j.trim.2024.102166_bb0025","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2002-11-3472","article-title":"Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation","volume":"102","author":"Hakki","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.trim.2024.102166_bb0030","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bmt.1705648","article-title":"Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients","volume":"39","author":"Heining","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"10.1016\/j.trim.2024.102166_bb0035","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3109\/14653249.2012.715243","article-title":"Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation","volume":"14","author":"Bosch","year":"2012","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.trim.2024.102166_bb0040","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbmt.2013.01.017","article-title":"Long-term immune reconstitution of naive and memory T cell pools after Haploidentical hematopoietic stem cell transplantation","volume":"19","author":"Azevedo","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.trim.2024.102166_bb0045","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbmt.2014.01.002","article-title":"Immune cell subset counts associated with graft-versus-host disease","volume":"20","author":"Podgorny","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.trim.2024.102166_bb0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cyto.b.21510","article-title":"Prognostic impact of lymphocyte Subpopulations in peripheral blood after hematopoietic stem cell transplantation for hematologic malignancies: prognostic role of lymphocyte subpopulations after HSCT","volume":"94","author":"Park","year":"2018","journal-title":"Cytometry B Clin. Cytom."},{"issue":"3","key":"10.1016\/j.trim.2024.102166_bb0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/bmt.2009.182","article-title":"Assessment of CD4 T-lymphocyte reactivity by the Cylex ImmuKnow assay in patients following allogeneic hematopoietic SCT","volume":"45","author":"Gesundheit","year":"2010","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.trim.2024.102166_bb0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.trim.2015.09.001","article-title":"CD4 T-cell function assay using Cylex ImmuKnow and lymphocyte subset recovery following allogeneic hematopoietic stem cell transplantation","volume":"33","author":"Jo","year":"2015","journal-title":"Transpl. Immunol."},{"issue":"8","key":"10.1016\/j.trim.2024.102166_bb0065","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/TP.0000000000000078","article-title":"A novel biomarker of immune function and initial experience in a transplant population","volume":"97","author":"Sood","year":"2014","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.trim.2024.102166_bb0070","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s12185-021-03206-7","article-title":"Assessment of cellular response to mitogens in long-term allogeneic hematopoietic stem cell transplantation survivors","volume":"114","author":"Sato","year":"2021","journal-title":"Int. J. Hematol."},{"issue":"2","key":"10.1016\/j.trim.2024.102166_bb0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-1759(89)90260-3","article-title":"Whole-blood lymphocyte cultures","volume":"122","author":"Bloemena","year":"1989","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"10.1016\/j.trim.2024.102166_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-2478(84)90003-8","article-title":"Detection of impaired mitogen responses in autologous whole blood of cancer patients using an optimized method of lymphocyte stimulation","volume":"8","author":"Fritze","year":"1984","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.trim.2024.102166_bb0085","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3389\/fimmu.2017.01506","article-title":"Low T-cell responses to mitogen stimulation predicts poor survival in recipients of allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Yong","year":"2017","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.trim.2024.102166_bb0090","doi-asserted-by":"crossref","first-page":"10693","DOI":"10.3390\/ijerph191710693","article-title":"Latent tuberculosis infection in Haematopoietic stem cell transplant recipients: a retrospective Italian cohort study in Tor Vergata university hospital, Rome","volume":"19","author":"Compagno","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.trim.2024.102166_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13260","article-title":"The QuantiFERON monitor\u00ae assay is predictive of infection post allogeneic hematopoietic cell transplantation","volume":"22","author":"Douglas","year":"2020","journal-title":"Transpl. Infect. Dis."},{"issue":"10","key":"10.1016\/j.trim.2024.102166_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074744","article-title":"Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV\u00ae assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications","volume":"8","author":"Tey","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.trim.2024.102166_bb0105","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/infdis\/jix192","article-title":"Identifying cytomegalovirus complications using the Quantiferon-CMV assay after allogeneic hematopoietic stem cell transplantation","volume":"215","author":"Yong","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.trim.2024.102166_bb0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.bmt.1703118","article-title":"Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen","volume":"28","author":"Morecki","year":"2001","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.trim.2024.102166_bb0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"12","key":"10.1016\/j.trim.2024.102166_bb0120","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.trim.2024.102166_bb0125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.trim.2024.102166_bb0130","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"33","key":"10.1016\/j.trim.2024.102166_bb0135","doi-asserted-by":"crossref","first-page":"14721","DOI":"10.1073\/pnas.1009220107","article-title":"Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation","volume":"107","author":"M\u00fcller","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.trim.2024.102166_bb0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.trim.2024.102166_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2016-06-686618","article-title":"Chronic graft-versus-host disease: biological insights from preclinical and clinical studies","volume":"129","author":"MacDonald","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.trim.2024.102166_bb0150","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","article-title":"Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation","volume":"39","author":"Godder","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"13","key":"10.1016\/j.trim.2024.102166_bb0155","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/j.1460-2075.1984.tb02285.x","article-title":"Phaseolus vulgaris phytohaemagglutinin (PHA) binds to the human T lymphocyte antigen receptor","volume":"3","author":"Chilson","year":"1984","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.trim.2024.102166_bb0160","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3109\/08923973.2011.561437","article-title":"In vitro modulation of natural killer activity of human peripheral blood mononuclear cells against prostate tumor cell line","volume":"33","author":"Sheikhi","year":"2011","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.trim.2024.102166_bb0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fimmu.2020.00191","article-title":"Key aspects of the Immunobiology of Haploidentical hematopoietic cell transplantation","volume":"11","author":"Baumeister","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.trim.2024.102166_bb0170","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3324\/haematol.2017.186619","article-title":"The early expansion of anergic NKG2Apos\/CD56dim\/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation","volume":"103","author":"Roberto","year":"2018","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.trim.2024.102166_bb0175","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/j.seminoncol.2012.09.009","article-title":"Genomic loss of mismatched human leukocyte antigen and leukemia immune escape from haploidentical graft-versus-leukemia","volume":"39","author":"Vago","year":"2012","journal-title":"Semin. Oncol."},{"issue":"4","key":"10.1016\/j.trim.2024.102166_bb0180","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41591-019-0400-z","article-title":"Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation","volume":"25","author":"Toffalori","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.trim.2024.102166_bb0185","article-title":"The yin-yang of immunity: immune dysregulation in myelodysplastic syndrome with different risk stratification","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.trim.2024.102166_bb0190","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.3390\/cancers14225656","article-title":"Bone marrow immune microenvironment in myelodysplastic syndromes","volume":"14","author":"Kouroukli","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.trim.2024.102166_bb0195","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bbmt.2018.12.767","article-title":"Development of grade II acute graft-versus-host disease is associated with improved survival after Myeloablative HLA-matched bone marrow transplantation using single-agent post-transplant cyclophosphamide","volume":"25","author":"McCurdy","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2024.102166_bb0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-023-01403-x","article-title":"GVHD occurrence does not reduce AML relapse following PTCy- based haploidentical transplantation: a study from the ALWP of the EBMT","volume":"16","author":"Baron","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.trim.2024.102166_bb0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40164-022-00278-x","article-title":"A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation","volume":"11","author":"Shen","year":"2022","journal-title":"Exp. Hematol. Oncol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327424001825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327424001825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T11:33:37Z","timestamp":1739100817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327424001825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":41,"alternative-id":["S0966327424001825"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2024.102166","relation":{},"ISSN":["0966-3274"],"issn-type":[{"type":"print","value":"0966-3274"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon gamma release assay has potential in the prediction of chronic graft-versus-host disease in recipients of myeloablative allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2024.102166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102166"}}